Mariagrazia Uguccioni

Università Della Svizzera Italiana Via Chiesa 5
Bellinzona, TI 6500, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach.

A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach.

Journal: Computational and structural biotechnology journal

Published: February 24, 2025

Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.

Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.

Journal: Frontiers in immunology

Published: December 20, 2023

Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential.

Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential.

Journal: RMD open

Published: November 20, 2023

The chemokine landscape: one system multiple shades.

The chemokine landscape: one system multiple shades.

Journal: Frontiers in immunology

Published: February 28, 2023

The interplay between previous infection and mental health condition on antibody response to COVID-19 mRNA vaccination.

The interplay between previous infection and mental health condition on antibody response to COVID-19 mRNA vaccination.

Journal: Brain, behavior, & immunity - health

Published: February 03, 2023

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.

Journal: Science immunology

Published: January 26, 2023

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.

Journal: bioRxiv : the preprint server for biology

Published: December 09, 2022

Tracking unlabeled cancer cells imaged with low resolution in wide migration chambers via U-NET class-1 probability (pseudofluorescence).

Tracking unlabeled cancer cells imaged with low resolution in wide migration chambers via U-NET class-1 probability (pseudofluorescence).

Journal: Journal of biological engineering

Published: August 09, 2022

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.

Journal: Nature immunology

Published: July 11, 2022

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course.

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course.

Journal: bioRxiv : the preprint server for biology

Published: June 06, 2022

Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19.

Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19.

Journal: Nature immunology

Published: March 09, 2022

Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction.

Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction.

Journal: Journal of medicinal chemistry

Published: September 13, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026